PsyMed Ventures
PsyMed Ventures is a community-focused fund and syndicate that provides capital and operational support to companies working on mental and brain health. The firm focuses on frontier technologies — including psychedelics and novel compounds, neurotechnology/BCI, precision neuroscience, digital therapeutics, AI-driven approaches, and new biologic modalities — and describes its mission as aligning healing, responsibility, and profitability.
Industries
Nr. of Employees
small (1-50)
Portfolio
Described as a precision psychiatry drug development platform.
#Precision psychiatry drug development platform
Described as CRISPR for live biotherapeutics and bacterial products.
#CRISPR-based live biotherapeutics and bacterial products
Platform with a pipeline of 10+ programs for brain and mental health.
#Drug development platform for brain and mental health
Drug development platform focused on neurological and psychiatric disorders.
#Drug development platform for neurological and psychiatric disorders
Develops novel ketamine formulations for pain management and mental health disorders.
#Novel ketamine formulations
Microbiome therapeutics platform for neurological disease.
#Microbiome therapeutics for neurological disease
Described as a precision psychiatry drug development platform.
#Precision psychiatry drug development platform
Described as CRISPR for live biotherapeutics and bacterial products.
#CRISPR-based live biotherapeutics and bacterial products
Platform with a pipeline of 10+ programs for brain and mental health.
#Drug development platform for brain and mental health
Drug development platform focused on neurological and psychiatric disorders.
#Drug development platform for neurological and psychiatric disorders
Develops novel ketamine formulations for pain management and mental health disorders.
#Novel ketamine formulations
Microbiome therapeutics platform for neurological disease.
#Microbiome therapeutics for neurological disease